BIVN Insider Trading Activity and SEC Form 4 Filings
BIVN insider trading summary
No open-market insider purchases or sales of Bioenvision Inc (BIVN) have been reported on SEC Form 4 in the past 12 months.
Latest BIVN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 10, 2007 | Wichita Bio CORP | 10% Owner | Buy | $48.8M (8,706,644 @ $5.60) |
| Jul 10, 2007 | Genzyme Corp | 10% Owner | Buy | $48.8M (8,706,644 @ $5.60) |
| Mar 9, 2006 | Thomas Scott Nelson | Director | Sell | $289K (37,500 @ $7.71) |
| Mar 8, 2006 | Thomas Scott Nelson | Director | Sell | $404K (52,500 @ $7.69) |
| Mar 6, 2006 | Hugh Griffith | Chief Operating Officer | Sell | $476K (60,000 @ $7.93) |
| Feb 28, 2006 | Hugh Griffith | Chief Operating Officer | Sell | $557K (65,000 @ $8.57) |
| Feb 28, 2006 | Ian Abercrombie | Sales Manager (Europe) | Sell | $430K (50,000 @ $8.59) |
| Sep 12, 2005 | Thomas Scott Nelson | Director | Sell | $178K (20,000 @ $8.92) |
| Sep 12, 2005 | Thomas Scott Nelson | Director | Sell | $179K (20,000 @ $8.96) |
| Sep 12, 2005 | Thomas Scott Nelson | Director | Sell | $133K (15,000 @ $8.88) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.